These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8645031)

  • 21. [A case of breast cancer with metastasis of multiple organs showing marked efficacy of medroxyprogesterone acetate (MPA)].
    Shimada K; Karaki Y; Ansai Y; Hino K; Yamashita Y; Fujimaki M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):623-6. PubMed ID: 8678522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea.
    Kim HJ; Lee JS; Park EH; Lim WS; Sei JY; Koh BS; Son BH; Ahn JH; Jeong KH; Kim SB; Ahn SH
    Eur J Surg Oncol; 2009 Sep; 35(9):936-41. PubMed ID: 19269125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.
    de Haes H; Olschewski M; Kaufmann M; Schumacher M; Jonat W; Sauerbrei W;
    J Clin Oncol; 2003 Dec; 21(24):4510-6. PubMed ID: 14610048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone-related events in breast cancer].
    Kurebayashi J
    Clin Calcium; 2008 Apr; 18(4):447-54. PubMed ID: 18379025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of breast cancer metastasis to the skin and bone 13 years after, and to the brain 17 years after mastectomy].
    Itoshima T; Yamamoto T; Kasamatsu T; Fujino H; Yamamoto H; Morita Y; Kodama M
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1331-3. PubMed ID: 9279355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
    Sakurai T; Tatematsu H; Yamataka K; Yamamoto T; Kawahara H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2029-34. PubMed ID: 11791380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LH-RH agonists offer very good protection against the adverse gynaecological effects induced by tamoxifen.
    Berlière M; Galant C; Marques G; Piette P; Duck L; Fellah L; Donnez J; Machiels JP
    Eur J Cancer; 2004 Aug; 40(12):1855-61. PubMed ID: 15288287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjuvant therapy during the administration of GnRH agonists].
    Nikolov A; Kolarov G
    Akush Ginekol (Sofiia); 2002; 41(2):36-40. PubMed ID: 12066551
    [No Abstract]   [Full Text] [Related]  

  • 29. [New period of systemic treatment for breast cancer].
    Hamaoka T
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1457-60. PubMed ID: 18799897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen level variations, clinical response to LHRH agonists and changes in the quality of life subscales in metastatic prostate cancer--speculations about possible role of the monoamine system.
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević Z
    Neoplasma; 1997; 44(5):308-13. PubMed ID: 9473791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase inhibitor withdrawal response in metastatic breast cancer.
    Cigler T; Goss PE
    J Clin Oncol; 2006 Apr; 24(12):1955-6. PubMed ID: 16622274
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases].
    Sueyoshi K; Ogura Y; Komori T; Takahashi M; Tian TX; Tatsumi T; Matsuki M; Saika Y; Uesugi Y; Utsunomiya K; Inomata Y; Narabayashi I
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1795-9. PubMed ID: 12402432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endocrine therapy for prostate cancer in the future].
    Usami M
    Gan To Kagaku Ryoho; 1998 May; 25(6):817-22. PubMed ID: 9617319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of premenopausal breast cancer showing remarkable elevation of serum alkaline phosphatase level during treatment with LH-RH analog.
    Ito K; Komatsu A; Kanai T; Koyama H; Hama Y; Shingu K; Fujimori M; Amano J
    Breast J; 2005; 11(6):523-4. PubMed ID: 16297128
    [No Abstract]   [Full Text] [Related]  

  • 35. CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
    von Minckwitz G; Graf E; Geberth M; Eiermann W; Jonat W; Conrad B; Brunnert K; Gerber B; Vescia S; Wollert J; Kaufmann M
    Eur J Cancer; 2006 Aug; 42(12):1780-8. PubMed ID: 16765589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous transplantation for patients with advanced breast cancer with emphasis on bony metastasis.
    Glück S
    Can J Oncol; 1995 Dec; 5 Suppl 1():58-62. PubMed ID: 8853527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of an orchiectomized patient with hormone-refractory prostate cancer with LH-RH agonists.
    Damyanov C; Tzingilev B; Tabakov V
    Eur Urol; 2001 Oct; 40(4):474-6; discussion 477. PubMed ID: 11713406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Breast cancer].
    Iwase H
    Nihon Rinsho; 2006 Sep; Suppl 3():379-83. PubMed ID: 17022569
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigation of menstruation recovery after LH-RH agonist therapy for premenopausal patients with breast cancer.
    Matsumoto M; Miyauchi M; Yamamoto N; Shishikura T; Imanaka N
    Breast Cancer; 2000; 7(3):237-40. PubMed ID: 11029804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.